Hill-Rom Holdings Inc (NYSE:HRC) gapped down prior to trading on Monday after Zacks Investment Research downgraded the stock from a hold rating to a sell rating. The stock had previously closed at $76.33, but opened at $74.74. Hill-Rom Holdings shares last traded at $74.17, with a volume of 352,702 shares trading hands.
Other equities research analysts have also recently issued research reports about the stock. Barclays PLC increased their target price on shares of Hill-Rom Holdings from $75.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, May 1st. Needham & Company LLC reduced their target price on shares of Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating for the company in a research note on Friday, July 28th. Cantor Fitzgerald assumed coverage on shares of Hill-Rom Holdings in a research note on Thursday, June 29th. They issued a “neutral” rating and a $86.00 target price for the company. Stifel Nicolaus increased their target price on shares of Hill-Rom Holdings from $70.00 to $84.00 and gave the company a “buy” rating in a research note on Monday, May 1st. Finally, ValuEngine upgraded shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. One analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $88.17.
In other Hill-Rom Holdings news, SVP Andreas G. Frank sold 10,660 shares of the firm’s stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $78.62, for a total transaction of $838,089.20. Following the completion of the transaction, the senior vice president now owns 28,988 shares in the company, valued at $2,279,036.56. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.20% of the stock is owned by company insiders.
The firm has a market capitalization of $4.82 billion, a PE ratio of 42.59 and a beta of 1.22. The company has a 50-day moving average price of $78.68 and a 200 day moving average price of $73.28.
Hill-Rom Holdings (NYSE:HRC) last posted its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.01. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The firm had revenue of $689.10 million during the quarter, compared to the consensus estimate of $695.50 million. During the same quarter in the previous year, the firm posted $0.81 EPS. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. On average, equities analysts expect that Hill-Rom Holdings Inc will post $3.82 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 15th will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date of this dividend is Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio (DPR) is presently 41.62%.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://www.com-unik.info/2017/08/19/hill-rom-holdings-inc-nysehrc-shares-gap-down-following-analyst-downgrade-updated-updated.html.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
What are top analysts saying about Hill-Rom Holdings Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Hill-Rom Holdings Inc and related companies.